Archive

Neovasc to Participate in Sidoti December Virtual Microcap Conference

  VANCOUVER and MINNEAPOLIS - (NewMediaWire) - December 01, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced that its management team will be participating in the Sidoti December Virtual Microcap Conference to be held December 8-9, 2021. Fred Colen, President and...

Read More

Neovasc Reducer™ System Receives National Reimbursement in France

First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 30, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ (Reducer) system has been granted Prise en Charge Transitoire (PECT) reimbursement in...

Read More

Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 09, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021. Third Quarter Highlights Strong progress against all three value creation strategies. Generated record revenue of approximately...

Read More

Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021

VANCOUVER - (NewMediaWire) - November 01, 2021 - Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host...

Read More

Neovasc Reducer Featured in Polish Heart Journal

  Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS - (NewMediaWire) - October 21, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ,TSX: NVCN) today announced that the Neovasc Reducer(TM) (Reducer) is featured in an article published in the...

Read More

Neovasc REDUCER-I Study Published in EuroIntervention Journal

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - September 28, 2021 - Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, Coronary sinus narrowing for the treatment of refractory angina: a multi-centre prospective open-label clinical study (the REDUCER-I study)...

Read More